Tilray | TRLY - Loan Capital

Stock Price
9.27
Daily Change
-0.28 -2.93%
Monthly
-14.17%
Yearly
918.68%
Q1 Forecast
9.24

Tilray reported $279.22M in Loan Capital for its fiscal quarter ending in March of 2025.





Loan Capital Change Date
Acasti Pharma USD 0 0 Dec/2024
Akebia Therapeutics USD 48.25M 609K Dec/2025
Alaunos Therapeutics USD 4.47M 5.85M Jun/2022
Aurora Cannabis CAD 34.99M 1.31M Sep/2025
Avita Medical AUD 42.24M 1.25M Dec/2024
Canopy Growth CAD 226.33M 62.67M Sep/2025
Dianthus Therapeutics USD 0 0 Dec/2024
Divis Laboratories Ltd INR 20M 0 Mar/2025
Ionis Pharmaceuticals USD 1.9B 1.87B Dec/2025
IQVIA Holdings USD 13.88B 1.09B Dec/2025
Knight Therapeutics CAD 84.7M 2.17M Sep/2025
Moderna USD 610M 584M Dec/2025
Organigram Holdings CAD 76.4M 23.6M Sep/2025
Organon & Co USD 8.78B 117M Sep/2025
Revvity USD 2.63B 543K Dec/2025
Tectonic Therapeutic USD 43K 57K Dec/2025
Tilray USD 279.22M 18.87M Mar/2025
Viatris USD 12.48B 7M Dec/2025
Xeris Pharmaceuticals USD 220.33M 866K Dec/2025